DANIELA LAZAR: Open Payments
NPI 1720648264 · TARZANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 50 payments from 9 companies in 2025. Trend: 2023 $199 · 2024 $547 · 2025 $1,662
Food & beverage: $1,464Education: $198
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $519 |
| Novo Nordisk Inc | 8 | $379 |
| E.R. Squibb & Sons, L.L.C. | 12 | $213 |
| Janssen Pharmaceuticals, Inc | 3 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $172 |
| Indivior Inc. | 2 | $63 |
| ABBVIE INC. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
Products named: Wegovy, UZEDY, COBENFY, SPRAVATO, CAPLYTA, SUBLOCADE, MAVYRET, Saxenda.
Industry payments across CA — which companies pay providers there.
